Title : FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.

Pub. Date : 2005

PMID : 16082080






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We hypothesized that combining low-dose FK506 with anti-CD40 Ligand (anti-CD40L mAb) would enhance regeneration through peripheral nerve allografts while preserving immune unresponsiveness. Tacrolimus CD40 ligand Mus musculus
2 RESULTS: Animals receiving low-dose FK506 with anti-CD40L mAb exhibited robust nerve regeneration comparable to the isograft and high-dose FK506 allograft groups. Tacrolimus CD40 ligand Mus musculus
3 Nerve density was significantly increased in the low-dose FK506 with anti-CD40L mAb group compared to animals receiving anti-CD40L mAb alone (p < 0.05). Tacrolimus CD40 ligand Mus musculus
4 CONCLUSION: When combined with anti-CD40L mAb, low-dose FK506 enhances nerve regeneration without disrupting immune unresponsiveness. Tacrolimus CD40 ligand Mus musculus